Cresco Labs Inc. (CSE:CL)

Market Cap	592.74M
Revenue (ttm)	921.56M
Net Income (ttm)	-72.70M
Shares Out	359.24M
EPS (ttm)	-0.21
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	94,458
Average Volume	668,813
Open	1.620
Previous Close	1.620
Day's Range	1.620 - 1.710
52-Week Range	0.600 - 3.120
Beta	1.73
RSI	52.56
Earnings Date	Mar 12, 2026

About Cresco Labs

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers canna...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 2,900
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: CL

Financial Performance

In 2024, Cresco Labs's revenue was $715.76 million, a decrease of -5.33% compared to the previous year's $756.06 million. Losses were -$74.44 million, -57.59% less than in 2023.

Financial numbers in USD